Emergence of H5N1 avian influenza viruses with reduced sensitivity to neuraminidase inhibitors and novel reassortants in Lao People's Democratic Republic
- 1 April 2010
- journal article
- Published by Microbiology Society in Journal of General Virology
- Vol. 91 (4), 949-959
- https://doi.org/10.1099/vir.0.017459-0
Abstract
Pandemic influenza viruses can emerge through continuous evolution and the acquisition of specific mutations or through reassortment. This study assessed the pandemic potential of H5N1 viruses isolated from poultry outbreaks occurring from July 2006 to September 2008 in the Lao People's Democratic Republic (PDR). We analyzed 29 viruses isolated from chickens and ducks and two from fatal human cases in 2007. Prior to 2008, all H5N1 isolates in Lao PDR were from clade 2.3.4; however, clade 2.3.2 was introduced in September 2008. Of greatest concern was the circulation of three isolates that showed reduced sensitivity to the neuraminidase (NA) inhibitor oseltamivir in an enzyme inhibition assay, each with different NA mutations – V116A, I222L and K150N, and a previously unreported S246N mutation. In addition, six isolates had an S31N mutation in the M2 protein, which conferred resistance to amantadine not previously reported in clade 2.3.4 viruses. Two H5N1 reassortants were isolated whose polymerase genes, PB1 and PB2, were homologous to those of Eurasian viruses giving rise to a novel H5N1 genotype, genotype P. All H5N1 viruses retained avian-like receptor specificity, but four had altered affinities for α2,3-linked sialic acid. This study shows that, in a genetically similar population of H5N1 viruses in Lao PDR, mutants emerged with natural resistance to antivirals and altered affinities for α2,3-linked sialic acids, together with reassortants with polymerase genes homologous to Eurasian viruses. These changes may contribute to the emergence of a pandemic influenza strain and are critical in devising surveillance strategies.Keywords
This publication has 44 references indexed in Scilit:
- The development and genetic diversity of H5N1 influenza virus in China, 1996–2006Virology, 2008
- Recent Avian H5N1 Viruses Exhibit Increased Propensity for Acquiring Human Receptor SpecificityJournal of Molecular Biology, 2008
- Novel Druggable Hot Spots in Avian Influenza Neuraminidase H5N1 Revealed by Computational Solvent Mapping of a Reduced and Representative Receptor EnsembleChemical Biology & Drug Design, 2008
- Epitope Mapping of the Hemagglutinin Molecule of a Highly Pathogenic H5N1 Influenza Virus by Using Monoclonal AntibodiesJournal of Virology, 2007
- An Avian Influenza H5N1 Virus That Binds to a Human-Type ReceptorJournal of Virology, 2007
- Avian Influenza Virus (H5N1): a Threat to Human HealthClinical Microbiology Reviews, 2007
- Emergence and predominance of an H5N1 influenza variant in ChinaProceedings of the National Academy of Sciences, 2006
- Natural Variation Can Significantly Alter the Sensitivity of Influenza A (H5N1) Viruses to OseltamivirAntimicrobial Agents and Chemotherapy, 2006
- Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptorsNature, 2006
- Universal primer set for the full-length amplification of all influenza A virusesArchiv für die gesamte Virusforschung, 2001